MedTrace Logo

Preventive Maintenance Therapy on Peri-implant Diseases

NCT02789306 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2017-04-25

No results posted yet for this study

Summary

In the field of periodontics, periodontal support therapy has proven to be essential in preventing the incidence or recurrence of periodontal diseases. The protocol is designed according to the risk profile of a patient. For example, in the presence of the history of periodontal therapy, subgingival microbiota containing large numbers of spirochetes and mobile rods can recolonize pockets 4-8 weeks after scaling. Similarly, routine maintenance of dental implants has been recommended to prudently avoid peri-implant inflammation, Indeed, the understanding of the nature of the tissue around the implant and its pattern of disease would be important to consider, even surpassing importance. Recently, a systematic review by our group has identified the importance of maintenance therapy around implants because it can help prevent about 3 times patient-level frequency peri-implantitis.

Henceforth, our primary goal was to study the influence in a cross-sectional study of the frequency of peri-implantitis patients according to their post-implant placement and corresponding prosthesis visits supportive peri-implant maintenance. As such, it will be shown:

1. What are the local and systemic factors affecting the appearance of peri-implantitis
2. The ideal frequency of supportive peri-implant maintenance in patients who do not develop peri-implant disease
3. What is the population of patients who come to supportive peri-implant maintenance after placement of dental implants

Conditions

  • Periimplantitis
  • Periodontal Disease

Interventions

PROCEDURE

Epidemiological study on the incidence of peri-implantitis

Clinical and radiographic examination in the routine based protocol

Sponsors & Collaborators

  • Universitat Internacional de Catalunya

    collaborator OTHER

  • Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-01-01
Completion
2017-03-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02789306 on ClinicalTrials.gov